COVID-19: can you become reinfected?
After the fear of getting sick with COVID-19, the biggest fear is getting infected again. What's the likelihood of becoming infected within a short...
COVID and monoclonal antibodies
Prevention is the way to go and vaccines are the example, but we must not forget the treatments that remain in continuous development. What's...
Predicting Coronavirus Variants
SARS-CoV-2 (like all RNA viruses) mutates rapidly and creates potentially more infectious and lethal variants. In the age of increasingly powerful computers, algorithms can...
Children in the Time of COVID: How the Role of Pediatricians is Changing
The pandemic we're currently experiencing has exposed all the weaknesses of modern medicine. Family physicians have organized themselves in many cases and have adapted...
Living with the Coronavirus – Part III
In this last article of our three-part "SARS-CoV-2 Coexistence" series, we'll try to explore a possible long-term scenario.
If in the first article we addressed...
Living with the Coronavirus – Part II
What will the scenario be like in 2022? Will we return to our normal lives or will we still be trapped in continued restrictions,...
Living with the Coronavirus – Part I
Almost all experts agree that SARS-CoV-2 will eventually become a seasonal flu. But what will the road to this perennial "coexistence" be like?
One thing...
COVID-19: Israel’s example and the UK’s strategy
Mass vaccination against SARS-Cov-2 in Israel demonstrates a 94% decrease in symptomatic cases.
Israel began its mass vaccination against SARS-Cov-2 on December 19, 2020, and...
The new Coronavirus variants
The UK, South African and Brazilian variants float like specters over our (precious few) certainties. Could these variants reduce the reliability of molecular testing...
Stem Cells against Coronavirus: the RESCAT study and the experiences of the Tettamanti Research...
In our body, we have natural allies against inflammation caused by SARS-CoV-2: we're talking about stem cells. However, how can they be used to...